by Vora Corporate Finance | Dec 16, 2024 | Insights, Private Equity & IPO
Transaction: Beta Drugs, a vertically integrated cancer firm, raised INR 117 crore in a funding round led by HealthQuadFund II, Inti Capital and Generational Capital for a minority stake in the company. The stake has been given through preferential allotment of...
by Vora Corporate Finance | Oct 28, 2023 | Insights, Private Equity & IPO
Transaction: India Resurgence Fund (IndiaRF), promoted by Piramal Enterprises Limited and Bain Capital, Invested Rs. 525 Crores in Ivy Health and Life Sciences Private Limited (Ivy). The hospital is estimated to be valued at Rs 1100 Crores. About India Resurgence Fund...
